Details for New Drug Application (NDA): 211928
✉ Email this page to a colleague
The generic ingredient in ETHOSUXIMIDE is ethosuximide. There is one drug master file entry for this compound. Eight suppliers are listed for this compound. Additional details are available on the ethosuximide profile page.
Summary for 211928
Tradename: | ETHOSUXIMIDE |
Applicant: | Strides Pharma |
Ingredient: | ethosuximide |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 211928
Physiological Effect | Decreased Central Nervous System Disorganized Electrical Activity |
Medical Subject Heading (MeSH) Categories for 211928
Suppliers and Packaging for NDA: 211928
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ETHOSUXIMIDE | ethosuximide | CAPSULE;ORAL | 211928 | ANDA | Strides Pharma Science Limited | 64380-878 | 64380-878-06 | 100 CAPSULE in 1 BOTTLE (64380-878-06) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 250MG | ||||
Approval Date: | Feb 19, 2019 | TE: | AB | RLD: | No |
Complete Access Available with Subscription